Return to homepagePandemic Pact

Development of a vaccine against COVID-19 based on recombinant BCG expressing SARS-Cov-2 antigenic determinants

Grant number: 401209/2020-2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    FAPESC Brazil

  • Research Location

    Brazil

  • Lead Research Institution

    UFSC - Universidade Federal de Santa Catarina

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

3 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.

From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics.

Guanylate binding proteins contained in the murine chromosome 3 are important to control mycobacterial infection.